Literature DB >> 8633168

Anatomic distribution of pulmonary emboli at pulmonary angiography: implications for cross-sectional imaging.

R F Oser1, D A Zuckerman, F R Gutierrez, J A Brink.   

Abstract

PURPOSE: To determine how often emboli detected angiographically in peripheral pulmonary arterial branches would be missed with cross-sectional imaging.
MATERIALS AND METHODS: Seventy-nine of 88 consecutive pulmonary angiograms interpreted as positive for pulmonary emboli were reviewed retrospectively to detect pulmonary emboli. Three angiograms interpreted as negative when reviewed retrospectively were excluded. Findings of 76 angiograms in 76 patients (32 men, 44 women; aged 19-85 years) were correlated with the results of scintigraphy (n = 72) and Doppler ultrasound (n = 60), clinical presentation (n = 76), and follow-up with chart review (n = 72).
RESULTS: Two hundred five emboli were identified. Nineteen patients had solitary emboli. Sixty emboli were in the upper lobes. The largest arterial branch with pulmonary embolism was lobar in 14 patients, segmental in 38, subsegmental in 20, and smaller in three.
CONCLUSION: If cross-sectional imaging can depict emboli in only segmental and larger arterial branches, then emboli in 23 of 76 patients (30%) would have been missed with cross-sectional imaging.

Entities:  

Mesh:

Year:  1996        PMID: 8633168     DOI: 10.1148/radiology.199.1.8633168

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  22 in total

1.  Pulmonary embolism: is multislice CT the method of choice? For.

Authors:  Ieneke J C Hartmann; Mathias Prokop
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

2.  Three-dimensional T2-weighted imaging using the dark blood method for detecting pulmonary embolisms: comparison with computed tomography angiography.

Authors:  Mitsutomi Ishiyama; Masaki Matsusako; Katsunori Oikado; Yutaro Nishi; Kuniomi Ohi; Masaharu Hirano; Yukihisa Saida
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

3.  Overdiagnosis of pulmonary embolism: evaluation of a hypoxia algorithm designed to avoid this catastrophic problem.

Authors:  Brian S Winters; Mark Solarz; Christina L Jacovides; James J Purtill; Richard H Rothman; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

Review 4.  Diagnosing pulmonary embolism: time to rewrite the textbooks.

Authors:  U Joseph Schoepf
Journal:  Int J Cardiovasc Imaging       Date:  2005-02       Impact factor: 2.357

5.  Reproducibility of multi-detector spiral computed tomography in detection of sub-segmental acute pulmonary embolism.

Authors:  S Brunot; O Corneloup; V Latrabe; M Montaudon; F Laurent
Journal:  Eur Radiol       Date:  2005-07-14       Impact factor: 5.315

Review 6.  V/Q scintigraphy: alive, well and equal to the challenge of CT angiography.

Authors:  Leonard M Freeman; Linda B Haramati
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

Review 7.  Computer-aided diagnosis of lung cancer and pulmonary embolism in computed tomography-a review.

Authors:  Heang-Ping Chan; Lubomir Hadjiiski; Chuan Zhou; Berkman Sahiner
Journal:  Acad Radiol       Date:  2008-05       Impact factor: 3.173

Review 8.  Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT.

Authors:  John H Reid; Emmanuel E Coche; Tomio Inoue; Edmund E Kim; Maurizio Dondi; Naoyuki Watanabe; Giuliano Mariani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-27       Impact factor: 9.236

9.  Detection of acute pulmonary embolism: feasibility of diagnostic accuracy of MRI using a stepwise protocol.

Authors:  Waldemar Hosch; Martin Schlieter; Sebastian Ley; Tobias Heye; Hans-Ulrich Kauczor; Martin Libicher
Journal:  Emerg Radiol       Date:  2013-11-27

Review 10.  Diagnosis of pulmonary embolism.

Authors:  Clive Kearon
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.